Filtros de búsqueda

Lista de obras de

A Randomized Open‐Label Trial with a Crossover Comparison of Sexual Self‐Confidence and Other Treatment Outcomes Following Tadalafil Once a Day Vs. Tadalafil or Sildenafil On‐Demand in Men with Erectile Dysfunction

artículo científico publicado el 16 de marzo de 2012

A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial

scientific article published on 03 October 2019

Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes

artículo científico publicado en 2015

Influence of Sildenafil on Genital Engorgement in Women with Female Sexual Arousal Disorder

artículo científico publicado el 23 de mayo de 2012

Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria

artículo científico publicado en 2018

Letter to the Editor: "Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia."

artículo científico publicado en 2019

Metabolomic markers reveal novel pathways of ageing and early development in human populations

scientific article published on 08 July 2013

Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome.

artículo científico publicado en 2006

Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome.

artículo científico publicado en 2008

Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies

scientific article published on 19 June 2019

Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trial

scientific article published on 30 April 2019

Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trial

artículo científico publicado en 2019

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

artículo científico publicado en 2021